Hepatocellular carcinoma (HCC) with extrahepatic metastasis (EHM) carries a poor prognosis, and treatment options after failure of anti-angiogenic targeted agents combined with immune checkpoint inhibitor (ICI) remain limited.
An adult patient with advanced HCC exhibited primary resistance to three sequent...
Qin Xu, Rui Zhu, Zi-Rui Wang et al.· Journal of Cancer Research a...· 0 citations
A case of a patient with advanced HCC who developed cutaneous, pulmonary, and lymphatic metastases following failure of multiple lines of tyrosine kinase inhibitors including donafenib and regorafenib is presented, highlighting the potential benefit of an EGFR-targeted triplet strategy in refractory HCC with EGFR prote...
Qin Xu, Xiao-Fen Li, Rui Zhu et al.· Frontiers in Immunology· 0 citations
A 3-gene mutational panel as risk stratification model could effectively predict OLK malignant transformation, outperforming pathological grading-based assessment and may provide a foundation for developing personalized management strategies.
Yuhan Zhu, Zi-Rui Wang, Chen-Xi Li et al.· Oral Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.